Petrovax Pharm is a Russian company prodicing novel biopharmaceutical practices, actively investing in scientific research and development. The product portfolio includes original pharmaceutical products and vaccines, biotech drugs, and branded generics. The company's complex manufacturing for APIs and finished dosage forms is located in the Moscow region and operates in full compliance with the EAEU and EU GMP standards. The company is one of the largest Russian exporters of original medicines and vaccines to the countries of the EAEU and the EU. Petrovax’s development strategy focuses on providing patients with novel vaccines and drugs for the prevention and treatment of infectious, oncological, and orphan diseases. Company’s mission: Expanding access to cutting-edge therapies.